DPMK Scientist / Sr. Scientist

Our Client is seeking a highly motivated and team-oriented candidate for the position of Scientist in the Drug Metabolism and Pharmacokinetics (DMPK) Department. The successful applicant will lead the development, validation, and application of cell based in vitro ADME assays to support our discovery and development programs. Reporting directly to the Senior Director of Clin Pharm, this is a unique opportunity to take on a role with a broad range of responsibilities and work in DMPK and Clinical Pharmacology. Core responsibilities: Utilize animal models, define efficacy, pharmacodynamics and translational principles for selection of development candidate molecules Conducts the analysis, interpretation and reporting of clinical and non-clinical pharmacokinetic data. Helps plan, conducts and reports quantitative analyses to select / optimize doses, dosage regimens throughout clinical drug development Experience with Simcyp, Monolix, Phoenix Winnonlin or other modeling software. PBPK experience and experience with DDI is crucial Qualifications: Must have 2+ years of experience in the pharma/ biotechnology industry or Post Doc. Ph.D./PharmD in Pharmacology, Biomedical Sciences, Pharmacokinetics or other discipline with appropriate experience Strong, demonstrable track record of scientific leadership excellence Demonstrated small molecule drug discovery experience: track-record of advancing multiple novel therapeutic agents from discovery into preclinical and subsequent clinical development as project team leader or member Experience in successfully selecting and managing CROs to provide high quality, timely and on-budget studies For more information please contact: TJ Elder Search Consultant Pre-Clinical Development O: 413.458.6124 C: 413.207.7676 https://www.linkedin.com/in/tjelder/ [email protected]<mailto:[email protected]> [cid:[email http://www.stem-sourcing.com/ Please Note: The information in this e-mail message is legally privileged and confidential information intended only for the use of the addressee(s) named above. If you, the reader of this message, are not the intended recipient, you are hereby notified that you should not further disseminate, distribute, or forward this e-mail message. If you have received this e-mail in error, please notify the sender as soon as possible. In addition, please delete the erroneously received message from any device/media where the message is stored.